FGFR4 and breast carcinoma: Since FGFR4 knockdown in MDA-MB-468 and HCC1937 decreases AKT phosphorylation, and AKT is known to play an essential role in cell survival [38, 39], we postulate that AKT hyperactivation may sustain the survival of these breast cancer cells.